|
GSK3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.098300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.360500E-02 |
| Normal-vs-Stage2 |
4.088200E-01 |
| Normal-vs-Stage3 |
1.728180E-01 |
| Normal-vs-Stage4 |
1.754040E-01 |
| Stage1-vs-Stage2 |
5.901600E-01 |
| Stage1-vs-Stage3 |
7.733200E-01 |
| Stage1-vs-Stage4 |
9.679800E-01 |
| Stage2-vs-Stage3 |
7.612800E-01 |
| Stage2-vs-Stage4 |
6.728200E-01 |
| Stage3-vs-Stage4 |
8.661800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.588830E-01 |
| Normal-vs-AfricanAmerican |
7.143500E-03 |
| Normal-vs-Asian |
6.297700E-02 |
| Caucasian-vs-AfricanAmerican |
1.090180E-02 |
| Caucasian-vs-Asian |
2.586200E-01 |
| AfricanAmerican-vs-Asian |
1.799630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.280200E-01 |
| Normal-vs-Female |
5.114000E-02 |
| Male-vs-Female |
5.452000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.072200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.001600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.104600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.693600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.411200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.915400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.325350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.317000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.877200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.464200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.429000E-01 |
| Classical-VS-Follicular |
7.017800E-03 |
| Classical-VS-Other |
2.361600E-01 |
| Classical-VS-Normal |
1.166260E-02 |
| Tall-VS-Follicular |
2.392400E-02 |
| Tall-VS-Other |
1.392200E-01 |
| Tall-VS-Normal |
2.121800E-02 |
| Follicular-VS-Other |
7.777000E-01 |
| Follicular-VS-Normal |
9.937000E-01 |
| Other-VS-Normal |
7.352600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.200000E-01 |
| Normal-vs-N1 |
2.528200E-01 |
| N0-vs-N1 |
5.593400E-01 |
|
|
